A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies

Histopathology

Volumn 48, Issue 6, 2006, Pages 644-654

  Melia, J ^a   Moseley, R ^b   Ball, R Y ^c   Griffiths, D F R ^d   Grigor, K ^e   Harnden, P ^f   Jarmulowicz, M ^g   McWilliam, L J ^h   Montironi, R ⁱ   Waller, M ^a   Moss, S ^a   Parkinson, M C ^j  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e WESTERN GENERAL HOSPITAL   (United Kingdom)

^f ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^g BOSTWICK LABORATORIES   (United States)

^h MANCHESTER ROYAL INFIRMARY   (United Kingdom)

ⁱ UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^j UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

more..

Author keywords

Biopsy; Grade; Observer variation; Prostate carcinoma; Reproducibility

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MALE; OBSERVER VARIATION; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REPRODUCIBILITY; SCORING SYSTEM; UNITED KINGDOM;

BIOPSY; GREAT BRITAIN; HUMANS; MALE; NEOPLASM STAGING; OBSERVER VARIATION; PATHOLOGY, CLINICAL; PROSTATE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 33645966840     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02393.x     Document Type: Article

References (52)

1. The Royal College of Pathologists. Standards and minimum datasets for reporting common cancersMinimum dataset for prostate cancer histopathology reports London The Royal College of Pathologists 2000
2. Eble JN Sauter G Epstein JI Sesterhenn IA WHO Classification of tumours Pathology and genetics of tumours of the urinary system and male genital organs Geneva World Health Organisation (IARC) 2004
3. Srigley JR Amin MB Humphrey PA Prostate glandProtocol applies to invasive carcinomas of the prostate gland Based on AJCC/UICC TNM 6th edn January 2003 Chicago College of American Pathologists 2003
4. Mellinger GT Gleason D Bailar J III. The histology and prognosis of prostatic cancer JUrol 1967 97 331 337
5. Albertsen PC Hanley JA Gleason DF Barry MJ Competing risk analysis of men aged 55-74 years at diagnosis managed conservatively for clinically localized prostate cancer JAMA 1998 280 975 980
6. Blute ML Bergstralh EJ Partin AW et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer JUrol 2000 164 1591 1595
7. Gancarczyk KJ Wu H McLeod DG et al. Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms Urology 2003 61 589 595
8. Narain V Bianco FJ Jr. Grignon DJ et al. How accurately does prostate biopsy Gleason score predict pathologic findings and disease free survival? Prostate 2001 49 185 190
9. Han M Partin AW Zahurak M et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer JUrol 2003 169 517 523
10. D'Amico AV Analysis of the clinical utility of the use of salvage brachytherapy in patients who have a rising PSA after definitive external beam radiation therapy Urology 1999 54 201 203
11. Martinez AA Pataki I Edmundson G et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report IntJRadiatOncolBiolPhys 2001 49 61 69
12. Kollmeier MA Stock RG Stone N Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality IntJRadiatOncolBiolPhys 2003 57 645 653
13. Potters L Purrazzella R Brustein S et al. The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy IntJRadiatOncolBiolPhys 2003 56 749 754
14. Sylvester JE Blasko JC Grimm PD Meier R Malmgren JA Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience IntJRadiatOncolBiolPhys 2003 57 944 952
15. Alagiri M Colton MD Seidmon EJ Greenberg RE Hanno PM The staging pelvic lymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancer BrJUrol 1997 80 243 246
16. Link RE Morton RA Indications for pelvic lymphadenectomy in prostate cancer UrolClinNorth Am 2001 28 491 498
17. Naya Y Babaian RJ The predictors of pelvic lymph node metastasis at radical retropubic prostatectomy JUrol 2003 170 2306 2310
18. O'Sullivan JM Norman AR Cook GJ Fisher C Dearnaley DP Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital BJU Int 2003 92 685 689
19. Lee N Fawaaz R Olsson CA et al. Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients IntJRadiatOncolBiolPhys 2000 48 1443 1446
20. Bocking A Sinagowitz E Histologic grading of prostatic carcinoma PatholResPract 1980 168 115 125
21. Schroeder FH Hop WC Blom JH Mostofi FK Grading of prostatic cancer. III. Multivariate analysis of prognostic parameters Prostate 1985 7 13 20
22. Epstein JI Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy. A diagnosis that should not be made AmJSurgPathol 2000 24 477 478
23. De Young BR Lynch CF Cohen MB Changes in frequency and grade of prostatic adenocarcinoma from 1973 to 1998 in a large population using SEER data USCAP Annual Meeting 2002 667 160A (Abstract)
24. Smith EB Frierson HF Jr. Mills SE Boyd JC Theodorescu D Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading? Cancer 2002 94 2282 2287
25. Allsbrook WC Jr. Mangold KA Johnson MH et al. Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists HumPathol 2001 32 74 80
26. Allsbrook WC Jr. Mangold KA Johnson MH et al. Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist HumPathol 2001 32 81 88
27. Griffiths DFR Melia J McWilliam J et al. A study of Gleason score interpretation in different groups of UK pathologists; techniques for improving reproducibility Histopathology 2006 DOI: 10.1111/j.1365-2559.2006.02394.x
28. Gleason DF Classification of prostatic carcinomas Cancer ChemotherRep 1966 50 125 128
29. Bostwick DG Dundore PA Biopsy pathology of the prostate (grading needle biopsies) London Chapman & Hall Medical 1997 141 166
30. Bain GO Koch M Hanson J Feasibility of grading prostatic carcinomas ArchPatholLabMed 1982 106 265 267
31. Cohen JA A coefficient of agreement for nominal scales EducPsycholMeasure 1960 20 37 46
32. Brennan P Silman A Statistical methods for assessing observer variability in clinical measures BMJ 1992 304 1491 1494
33. Fleiss JL Measuring nominal scale agreement among many raters PsycholBull 1971 76 378 382
34. Boyd NF Wolfson C Moskowitz M et al. Observer variation in the classification of mammographic parenchymal patterns JChronDis 1986 39 465 472
35. Lessells AM Burnett RA Howatson SR et al. Observer variability in the histopathological reporting of needle biopsy specimens of the prostate HumPathol 1997 28 646 649
36. di Loreto C Fitzpatrick B Underhill S et al. Correlation between visual clues, objective architectural features, and interobserver agreement in prostate cancer AmJClinPathol 1991 96 70 75
37. Ozdamar SO Sarikaya S Yildiz L et al. Intraobserver and interobserver reproducibility of WHO and Gleason histologic grading systems in prostatic adenocarcinomas IntUrolNephrol 1996 28 73 77
38. Rousselet MC Saint-Andre JP Six P Soret JY Reproducibility and prognostic value of Gleason and Gaeta histological classifications in prostatic cancer AnnUrol 1986 20 317 322
39. Svanholm H Mygind H Prostatic carcinoma reproducibility of histologic grading Acta PatholMicrobiolImmunolScand 1985 93 67 71
40. ten Kate FJ Gallee MPW Schmitz PIM et al. Problems in grading of prostatic carcinoma: interobserver reproducibility of five different grading systems World JUrol 1986 4 147 152
41. Gleason DF Histologic grading of prostate cancer: a perspective HumPathol 1992 23 273 279
42. Ghani KR Grigor K Tulloch DN Bollina PR McNeill SA Trends in reporting Gleason Score 1991-2001: changes in the pathologist's practice EurUrol 2005 47 196 201
43. Nicholson PW Harland SJ Survival prospects after screen-detection of prostate cancer BJU Int 2002 90 686 693
44. Kondylis FI Moriarty RP Bostwick D Schellhammer PF Prostate cancer grade assignment: the effect of chronological, interpretive and translation bias JUrol 2003 170 1189 1193
45. Bott SR Freeman HP Stenning A Cohen J Parkinson MC Radical prostatectomy: pathology findings in 1001 cases compared with other major series over time BJU Int 2005 95 34 39
46. Han M Partin AW Piantadosi S Epstein JI Walsh PC Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer JUrol 2001 166 416 419
47. Steinberg DM Sauvageot J Piantadosi S Epstein JI Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings AmJSurgPathol 1997 21 566 576
48. Cookson MS Fleshner NE Soloway SM Fair WR Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications JUrol 1997 157 559 562
49. Renshaw AA Schultz D Cote K et al. Accurate Gleason grading of prostatic adenocarcinoma in prostate needle biopsies by general pathologists ArchPatholLabMed 2003 127 1007 1008
50. Makarov DV Sanderson H Partin AW Epstein JI Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores? JUrol 2002 167 2440 2442
51. Pan CC Potter SR Partin AW Epstein JI The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system AmJSurgPathol 2000 24 563 569
52. Sooriakumaran P Lovell DP Henderson A Denham P Langley SEM Laing RW Gleason scoring varies among pathologists and this affects clinical risk in patients with prostate cancer ClinOncol 2005 17 655 658